Hubei Biocause Heilen Pharmaceutical Co., Ltd. 301211.SZ Stock
16.78 CNY
{{ price }}
-1.236016%
{{change_pct}}%
SECTOR
Basic Materials
INDUSTRY
Chemicals
COUNTRY
China
Exchange
Shenzhen
Market Cap
4.83B CNY
LOW - HIGH [24H]
16.18
-
17.17 CNY
VOLUME [24H]
1.32M CNY
{{ volume }}
P/E Ratio
25.42
Earnings per share
0.66 CNY
Hubei Biocause Heilen Pharmaceutical Co., Ltd. Price Chart
Hubei Biocause Heilen Pharmaceutical Co., Ltd. 301211.SZ Financial and Trading Overview
Contents
- Hubei Biocause Heilen Pharmaceutical Co., Ltd. Price Chart
- Hubei Biocause Heilen Pharmaceutical Co., Ltd. 301211.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Hubei Biocause Heilen Pharmaceutical Co., Ltd.
- Q&A For Hubei Biocause Heilen Pharmaceutical Co., Ltd. Stock
| Hubei Biocause Heilen Pharmaceutical Co., Ltd. stock price | 16.78 CNY |
| Previous Close | 27 CNY |
| Open | 27.4 CNY |
| Bid | 27.23 CNY x N/A |
| Ask | 27.24 CNY x N/A |
| Day's Range | 27.12 - 27.88 CNY |
| 52 Week Range | 13.29 - 46.88 CNY |
| Volume | 6.82M CNY |
| Avg. Volume | 15.07M CNY |
| Market Cap | 7.85B CNY |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 55.591835 |
| EPS (TTM) | 0.66 CNY |
| Forward Dividend & Yield | 0.4 (1.45%) |
| Ex-Dividend Date | May 31, 2023 |
| 1y Target Est | N/A |
301211.SZ Valuation Measures
| Enterprise Value | 5.97B CNY |
| Trailing P/E | 55.591835 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.527181 |
| Price/Book (mrq) | 3.386375 |
| Enterprise Value/Revenue | 10.292 |
| Enterprise Value/EBITDA | 52.685 |
Trading Information
Hubei Biocause Heilen Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 54.80% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 46.88 CNY |
| 52 Week Low | 13.29 CNY |
| 50-Day Moving Average | 26.03 CNY |
| 200-Day Moving Average | 24.11 CNY |
301211.SZ Share Statistics
| Avg. Volume (3 month) | 15.07M CNY |
| Avg. Daily Volume (10-Days) | 13.48M CNY |
| Shares Outstanding | 288M |
| Float | 121.5M |
| Short Ratio | N/A |
| % Held by Insiders | 75.85% |
| % Held by Institutions | 1.11% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.333 |
| Trailing Annual Dividend Yield | 1.23% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.5263 |
| Last Split Factor | 1.2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 23.73% |
| Operating Margin (ttm) | 15.97% |
| Gross Margin | 29.18% |
| EBITDA Margin | 19.53% |
Management Effectiveness
| Return on Assets (ttm) | 2.39% |
| Return on Equity (ttm) | 6.02% |
Income Statement
| Revenue (ttm) | 579.95M CNY |
| Revenue Per Share (ttm) | 2 CNY |
| Quarterly Revenue Growth (yoy) | 50.70% |
| Gross Profit (ttm) | 148.69M CNY |
| EBITDA | 113.3M CNY |
| Net Income Avi to Common (ttm) | 137.68M CNY |
| Diluted EPS (ttm) | 0.49 |
| Quarterly Earnings Growth (yoy) | 42.79% |
Balance Sheet
| Total Cash (mrq) | 1.93B CNY |
| Total Cash Per Share (mrq) | 6.7 CNY |
| Total Debt (mrq) | 7.47M CNY |
| Total Debt/Equity (mrq) | 0.32 CNY |
| Current Ratio (mrq) | 14.486 |
| Book Value Per Share (mrq) | 8.044 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 176.21M CNY |
| Levered Free Cash Flow (ttm) | 15.43M CNY |
Profile of Hubei Biocause Heilen Pharmaceutical Co., Ltd.
| Country | China |
| State | N/A |
| City | Jingmen |
| Address | 122-132 Yangwan Road |
| ZIP | 448000 |
| Phone | 86 27 6565 1730 |
| Website | https://biocause.com |
| Industry | Chemicals |
| Sector(s) | Basic Materials |
| Full Time Employees | 953 |
Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China. It provides APIs and intermediates, and formulations; and dimethyl ether gas and chloropropionyl chloride chemical products. The company is based in Jingmen, China.
Q&A For Hubei Biocause Heilen Pharmaceutical Co., Ltd. Stock
What is a current 301211.SZ stock price?
Hubei Biocause Heilen Pharmaceutical Co., Ltd. 301211.SZ stock price today per share is 16.78 CNY.
How to purchase Hubei Biocause Heilen Pharmaceutical Co., Ltd. stock?
You can buy 301211.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hubei Biocause Heilen Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Hubei Biocause Heilen Pharmaceutical Co., Ltd. is 301211.SZ.
Which industry does the Hubei Biocause Heilen Pharmaceutical Co., Ltd. company belong to?
The Hubei Biocause Heilen Pharmaceutical Co., Ltd. industry is Chemicals.
How many shares does Hubei Biocause Heilen Pharmaceutical Co., Ltd. have in circulation?
The max supply of Hubei Biocause Heilen Pharmaceutical Co., Ltd. shares is 288M.
What is Hubei Biocause Heilen Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hubei Biocause Heilen Pharmaceutical Co., Ltd. PE Ratio is 25.42424200 now.
What was Hubei Biocause Heilen Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hubei Biocause Heilen Pharmaceutical Co., Ltd. EPS is 0.66 CNY over the trailing 12 months.
Which sector does the Hubei Biocause Heilen Pharmaceutical Co., Ltd. company belong to?
The Hubei Biocause Heilen Pharmaceutical Co., Ltd. sector is Basic Materials.